TELA TELA Bio, Inc. - Common stock
NASDAQ · Health Care · SEC EDGAR'da Görüntüle ↗ kapat Eki 2, 2026 10-K/10-Q Ağu 11, 2026
$1,14
· 52 haftalık aralığın %'i
· düşüğün üstünde
· yükseğe
$0,5052 haftanın en düşüğü
$1,6052 haftanın en yükseği
Piyasa Değeri (MRQ)
$51M
P/E (TTM)
-1.5
Hisse Başına Kâr (TTM)
$-0.77
Gelir (TTM)
$80M
rozetleriniz
52 Haftlık Aralık
$1–$2
Analist Derecelendirmesi
BUY
Fiyat Hedefi
$2
P/E
-1.5
ROE
1232.5%
Net Kâr Marjı
-51.5%
Rozet şeridiniz boş — bu sayfada herhangi bir metriği sabitleyin.
TELA Hisse Senedi Özeti Fiyat, piyasa değeri, P/E, EPS, ROE, borç/öz sermaye, 52 haftalık aralık
Fiyat
$1.14
Piyasa Değeri (MRQ)
$51M
P/E (TTM)
-1.5
Hisse Başına Kâr (TTM)
$-0.77
Gelir (TTM)
$80M
ROE (TTM)
1232.5%
D/E Borç/Özsermaye (MRQ)
-3.5
52 Haftlık Aralık
$1–$2
TELA Hisse Senedi Fiyat Grafiği Teknik göstergeler ile günlük OHLCV — kaydır, yakınlaştır ve görünümünüzü özelleştirin
aralık
çubuklar
Çubuk çözünürlüğü seçilen döneme uyum sağlar — bir çubuk için açılış/yüksek/düşük/kapanış değerlerini görmek için grafiğin üzerine gelin.
10 Yıllık Performans Gelir, net kar, marjlar ve EPS trendleri
Gelir$80M2017-12-31 → 2025-12-31
Hisse Başına Kâr$-0.832019-12-31 → 2025-12-31
Serbest Nakit Akışı$-29M2019-12-31 → 2025-12-31
Net kar marjı-51.5%2019-12-31 → 2025-12-31
Değerleme ve Oranlar
Değerleme P/E, P/S, P/B, EV/EBITDA oranları — hisse senedi pahalı mı ucuz mu?
| Metrik | 5 Yıllık trend | TELA | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| P/E (TTM) | -1.55Y ort. ≈-3.3 | ≈-3.3 | · | · | |
| F/S (TTM) | 0.65Y ort. ≈3.4 | ≈3.4 | 1.9 | Düşük değerli | |
| F/D (MRQ) | -3.25Y ort. ≈9.2 | ≈9.2 | · | · | |
| EV / EBITDA | -1.65Y ort. ≈-3.5 | ≈-3.5 | · | · | |
| Fiyat / Serbest Nakit Akışı (TTM) | -1.65Y ort. ≈-4.0 | ≈-4.0 | · | · | |
| Fiyat / Nakit Akışı (TTM) | -1.65Y ort. ≈-4.0 | ≈-4.0 | · | · | |
| EV / Revenue (EV / Gelir) | 0.75Y ort. ≈2.6 | ≈2.6 | · | · | |
| EV / FCF | -1.95Y ort. ≈-3.4 | ≈-3.4 | · | · | |
| Fiyat / Maddi Defter Değeri (MRQ) | -3.05Y ort. ≈10.8 | ≈10.8 | · | · |
Akran ortalaması, metrik başına standartlaştırılmış bir temelde hesaplanır ve bu hisse senedi için gösterilen TTM/MRQ temelini her zaman eşleşmeyebilir.
Kârlılık Brüt, faaliyet ve net kâr marjları; ROE, ROA, ROIC
| Metrik | 5 Yıllık trend | TELA | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Brüt Kar Marjı (TTM) | 67.8%5Y ort. ≈66.5% | ≈66.5% | 39.2% | En üst düzey | |
| Faaliyet Kâr Marjı (TTM) | -42.6%5Y ort. ≈-72.2% | ≈-72.2% | -40.8% | Zayıf | |
| EBITDA Margin (FAVÖK Marjı) | -42.0%5Y ort. ≈-72.2% | ≈-72.2% | -23.4% | Zayıf | |
| Vergi Öncesi Kar Marjı (TTM) | -51.2% | · | -35.6% | Zayıf | |
| Net Kâr Marjı (TTM) | -51.5%5Y ort. ≈-80.5% | ≈-80.5% | -47.1% | Ortalamanın altında | |
| ROA (TTM) | -64.7%5Y ort. ≈-53.8% | ≈-53.8% | -29.3% | Ortalamanın altında | |
| ROE (TTM) | 1232.5%5Y ort. ≈-281.2% | ≈-281.2% | -72.5% | Zayıf | |
| ROIC | -54.8% | · | -17.5% | Zayıf |
Finansal Sağlık Borç, likidite, solventlik — bilanço gücü
| Metrik | 5 Yıllık trend | TELA | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Borç / Öz Sermaye (MRQ) | -3.55Y ort. ≈3.8 | ≈3.8 | · | · | |
| Cari Oran (MRQ) | 3.05Y ort. ≈4.8 | ≈4.8 | 4.1 | Düşük likidite | |
| Quick Ratio (Cari Oran) | 3.45Y ort. ≈3.8 | ≈3.8 | 2.8 | Düşük likidite | |
| Uzun Vadeli Borç / Özkaynak (MRQ) | -3.55Y ort. ≈3.8 | ≈3.8 | · | · |
Büyüme Gelir, EPS ve net gelir büyümesi: YOY, 3 Yıllık CAGR, 5 Yıllık CAGR
| Metrik | 5 Yıllık trend | TELA | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Revenue YoY (Gelir Yıllık Bazda) | 15.8%5Y ort. ≈35.6% | ≈35.6% | · | · | |
| Revenue CAGR 3Y (Gelir 3 Yıllık Bileşik Büyüme Oranı) | 24.7%5Y ort. ≈35.1% | ≈35.1% | · | · | |
| Revenue CAGR 5Y (Gelir 5 Yıllık Bileşik Büyüme Oranı) | 34.5% | · | · | · |
Sermaye Verimliliği Aktif devir hızı, stok devir hızı, alacak devir hızı
| Metrik | 5 Yıllık trend | TELA | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Asset Turnover (Aktif Devir Hızı) | 1.05Y ort. ≈0.7 | ≈0.7 | 0.4 | En üst düzey | |
| Receivables Turnover (Alacak Devir Hızı) | 7.95Y ort. ≈7.6 | ≈7.6 | 7.9 | Aynı seviyede | |
| Revenue / Employee (Çalışan Başına Gelir) | ≈$368.2K | · | · | · |
değer · ≈ 5Y ort. · sektör ortalaması · ortalamaya göre değerlendirme
Kazanç Geçmişi EPS gerçekleşen vs tahmin, sürpriz %, kazanma oranı, bir sonraki kazanç tarihi
Ort. Sürpriz
-7.5%
Sonraki Rapor
Kas 11, 2026
| Dönem | Rapor | EPS Gerçek | EPS Tahmin | Sürpriz |
|---|---|---|---|---|
| 30 Haziran 2026 | Ağu 12, 2026 | $-0.20 | $-0.18 | -10.0% |
| 31 Mart 2026 | May 12, 2026 | $-0.21 | $-0.19 | -9.4% |
| 31 Aralık 2025 | $-0.17 | $-0.19 | 8.7% | |
| 30 Eylül 2025 | $-0.19 | $-0.20 | 6.4% | |
| 30 Haziran 2025 | $-0.22 | $-0.18 | -22.0% | |
| 31 Mart 2025 | $-0.25 | $-0.20 | -25.3% | |
| 31 Aralık 2024 | $-0.23 | $-0.23 | -1.2% |
Tüm Temeller Tüm metrikler yıla göre — gelir tablosu, bilanço, nakit akışı
Gelir Tablosu
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $80M | $69M | $58M | $41M | $29M | $18M | $15M | $8M | |
| Gross Profit | $54M | $46M | $40M | $27M | $19M | $11M | $9M | $3M | |
| R&D Expense | $9M | $9M | $10M | $9M | $7M | $4M | $4M | $4M | |
| SG&A Expense | $16M | $15M | $15M | $14M | $12M | $10M | $6M | $5M | |
| Operating Expenses | $88M | $88M | $84M | $66M | $48M | $37M | $28M | $21M | |
| Operating Income | $-34M | $-34M | $-44M | $-39M | $-29M | $-25M | $-19M | $-18M | |
| Interest Expense | · | · | $5M | $4M | $4M | $4M | $4M | $2M | |
| Other Non-op | $1M | $1M | $3M | $-10.0K | $-228.0K | $45.0K | $351.0K | $70.0K | |
| Pretax Income | $-39M | $-38M | $-47M | $-44M | · | · | · | · | |
| Income Tax | $230.0K | $-144.0K | · | · | · | · | · | · | |
| Net Income | $-39M | $-38M | $-47M | $-44M | $-33M | $-29M | $-22M | $-21M | |
| EPS (Basic) | $-0.83 | $-1.33 | $-2.04 | $-2.72 | $-2.30 | $-2.23 | $-17.10 | · | |
| EPS (Diluted) | $-0.83 | $-1.33 | $-2.04 | $-2.72 | $-2.30 | $-2.23 | $-17.10 | · | |
| Shares (Basic) | 46,947,932 | 28,526,441 | 22,868,663 | 16,267,678 | 14,473,213 | 12,934,421 | 1,766,412 | · | |
| Shares (Diluted) | 46,947,932 | 28,526,441 | 22,868,663 | 16,267,678 | 14,473,213 | 12,934,421 | 1,766,412 | · | |
| EBITDA | $-34M | $-34M | $-44M | $-39M | $-29M | $-25M | $-19M | · |
Bilanço
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $51M | $53M | $47M | $42M | $44M | $74M | $45M | $17M | |
| Short-term Investments | · | · | · | · | · | $0 | $9M | · | |
| Receivables | $10M | $10M | $10M | $7M | $4M | $3M | $3M | $1M | |
| Inventory | $11M | $13M | $13M | $12M | $8M | $4M | $5M | $4M | |
| Prepaid Expense | $3M | $3M | $2M | $2M | $3M | $2M | $2M | $330.0K | |
| Current Assets | $76M | $78M | $72M | $62M | $59M | $83M | $64M | $23M | |
| PP&E (Net) | $2M | $2M | $2M | $2M | $1M | $626.0K | $677.0K | $758.0K | |
| PP&E (Gross) | $6M | $7M | $6M | $6M | $5M | $4M | $4M | $4M | |
| Accum. Depreciation | $3M | $5M | $4M | $4M | $4M | $4M | $4M | $3M | |
| Intangibles | $1M | $2M | $2M | $2M | $2M | $3M | $3M | · | |
| Other Non-current Assets | $500.0K | $2M | · | · | · | · | · | · | |
| Total Assets | $81M | $87M | $78M | $68M | $63M | $86M | $68M | $27M | |
| Accounts Payable | $2M | $2M | $2M | $2M | $2M | $652.0K | $3M | $3M | |
| Accrued Liabilities | $16M | $13M | $15M | $11M | $8M | $6M | $4M | $5M | |
| Current Liabilities | $18M | $16M | $17M | $12M | $11M | $7M | $7M | $10M | |
| Capital Leases | · | $2M | $2M | $1M | · | · | · | · | |
| Other Non-current Liabilities | $1M | $1M | $2M | $1M | $380.0K | · | $4.0K | $5.0K | |
| Total Liabilities | $75M | $58M | $59M | $54M | $42M | $37M | $37M | $41M | |
| Long-term Debt | · | $41M | $41M | $40M | $31M | $31M | $30M | · | |
| Total Debt | $56M | $41M | $41M | $40M | · | · | · | · | |
| Common Stock | $44.0K | $39.0K | $24.0K | $19.0K | $15.0K | $14.0K | $11.0K | · | |
| Paid-in Capital | $404M | $387M | $340M | $288M | $250M | $246M | $199M | · | |
| Retained Earnings | $-398M | $-359M | $-321M | $-274M | $-230M | $-197M | $-168M | $-138M | |
| AOCI | $91.0K | $90.0K | $91.0K | $150.0K | $-52.0K | $-71.0K | $-19.0K | · | |
| Stockholders' Equity | $6M | $28M | $19M | $14M | $20M | $49M | $31M | $-138M | |
| Liabilities + Equity | $81M | $87M | $78M | $68M | $63M | $86M | $68M | $27M | |
| Shares Outstanding | 44,538,264 | 39,395,712 | 24,494,675 | 19,165,027 | 14,529,577 | 14,437,107 | 11,406,221 | 295,717 |
Nakit Akışı
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $4M | $4M | $5M | $4M | $4M | $2M | $457.0K | $216.0K | |
| Deferred Tax | $144.0K | $-144.0K | · | · | · | · | · | · | |
| Operating Cash Flow | $-28M | $-42M | $-41M | $-41M | $-30M | $-24M | $-26M | $-20M | |
| CapEx | $448.0K | $989.0K | $611.0K | $872.0K | $627.0K | $167.0K | $197.0K | $62.0K | |
| Investing Cash Flow | $846.0K | $4M | $-599.0K | $-2M | $-627.0K | $9M | $-12M | $-2M | |
| Debt Issued | · | · | · | $40M | · | · | · | · | |
| Net Debt Issued | $-42M | · | · | $10M | · | · | · | · | |
| Stock Issued | · | · | $46M | $34M | · | $45M | · | · | |
| Net Stock Activity | · | · | $46M | $34M | · | $34.0K | · | · | |
| Financing Cash Flow | $26M | $43M | $46M | $41M | $585.0K | $44M | $66M | $27M | |
| Net Change in Cash | $-2M | $6M | $5M | $-2M | $-30M | $29M | $28M | $6M | |
| Taxes Paid | $0 | · | · | · | · | · | · | · | |
| Free Cash Flow | $-29M | $-43M | $-41M | $-42M | $-31M | $-25M | $-26M | · |
Kârlılık
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 67.7% | 67.1% | 68.6% | 65.3% | 63.8% | 61.7% | 60.0% | · | |
| Operating Margin | -42.0% | -49.2% | -75.4% | -94.2% | -100.0% | -138.8% | -124.1% | · | |
| Net Margin | -48.4% | -54.6% | -79.8% | -106.9% | -112.9% | -158.1% | -145.2% | · | |
| Pretax Margin | -48.1% | -54.8% | · | · | · | · | · | · | |
| EBITDA Margin | -42.0% | -49.2% | -75.4% | -94.2% | -100.0% | -138.8% | -124.1% | · | |
| ROA | -46.2% | -46.0% | -64.0% | -67.9% | -44.7% | -37.3% | -47.1% | · | |
| ROE | -501.1% | -341.1% | -188.8% | -235.6% | -139.2% | -54.7% | 34.6% | · | |
| ROIC | -54.8% | -48.8% | · | · | · | · | · | · |
Likidite ve Solventlik
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 4.2 | 5.0 | 4.2 | 5.0 | 5.6 | 12.6 | 9.6 | · | |
| Quick Ratio | 3.4 | 4.0 | 3.3 | 3.9 | 4.6 | 11.7 | 8.6 | · | |
| Debt / Equity | 8.8 | 1.4 | 2.1 | 2.8 | · | · | · | · | |
| LT Debt / Equity | 8.8 | 1.4 | 2.1 | 2.8 | · | · | · | · | |
| Interest Coverage | · | · | -8.4 | -9.6 | -8.2 | -7.1 | -5.3 | · |
Verimlilik
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 1.0 | 0.8 | 0.8 | 0.6 | 0.4 | 0.2 | 0.3 | · | |
| Receivables Turnover | 7.9 | 7.0 | 7.1 | 7.6 | 8.5 | 6.6 | 7.5 | · |
Hisse Başına
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $0.14 | $0.72 | $0.77 | $0.75 | $1.38 | $3.40 | $2.71 | · | |
| Revenue / Share | $1.71 | $2.43 | $2.56 | $2.55 | $2.04 | · | · | · | |
| Cash Flow / Share | $-0.60 | $-1.46 | $-1.79 | $-2.50 | $-2.10 | · | · | · | |
| Cash / Share | $1.14 | $1.34 | $1.91 | $2.19 | $3.02 | $5.15 | $3.97 | · | |
| EPS (TTM) | $-0.83 | $-1.33 | $-2.04 | $-2.72 | $-2.30 | $-2.23 | $-17.10 | · |
Büyüme Oranları
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 15.8% | 18.6% | 41.1% | 40.6% | 61.8% | · | · | · | |
| Revenue CAGR 3Y | 24.7% | 33.0% | 47.5% | · | · | · | · | · | |
| Revenue CAGR 5Y | 34.5% | · | · | · | · | · | · | · |
Değerleme (TTM)
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $80M | $69M | $58M | $41M | $29M | $18M | $15M | · | |
| Net Income TTM | $-39M | $-38M | $-47M | $-44M | $-33M | $-29M | $-22M | · | |
| Market Cap | $53M | $119M | $162M | $220M | $186M | $217M | $148M | · | |
| Enterprise Value | $57M | $107M | $156M | $218M | · | · | · | · | |
| P/E | -1.4 | -2.3 | -3.2 | -4.2 | -5.6 | -6.7 | -0.8 | · | |
| P/S | 0.7 | 1.7 | 2.8 | 5.3 | 6.3 | 11.9 | 9.6 | · | |
| P/B | 8.3 | 4.2 | 8.6 | 15.4 | 9.3 | 4.4 | 4.8 | · | |
| P / Tangible Book | 10.6 | 4.5 | 9.7 | 18.7 | 10.5 | 4.7 | · | · | |
| P / Cash Flow | -1.9 | -2.9 | -4.0 | -5.4 | -6.1 | -8.9 | -5.8 | · | |
| P / FCF | -1.8 | -2.8 | -3.9 | -5.3 | -6.0 | -8.8 | -5.7 | · | |
| EV / EBITDA | -1.7 | -3.1 | -3.5 | -5.6 | · | · | · | · | |
| EV / FCF | -2.0 | -2.5 | -3.8 | -5.2 | · | · | · | · | |
| EV / Revenue | 0.7 | 1.6 | 2.7 | 5.3 | · | · | · | · | |
| Earnings Yield | -70.3% | -44.0% | -30.8% | -23.6% | -18.0% | -14.8% | -132.1% | · |
Gelir Tablosu
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $19M | $19M | $21M | $21M | $20M | $19M | $18M | $19M | $16M | $17M | $15M | $14M | $12M | $12M | $11M | $10M | |
| Gross Profit | $14M | $13M | $14M | $14M | $14M | $13M | $11M | $13M | $11M | $11M | $10M | $10M | $8M | $8M | $7M | $7M | |
| R&D Expense | $3M | $2M | $2M | $2M | $2M | $3M | $2M | $2M | $2M | $2M | $2M | $3M | $2M | $3M | $2M | $2M | |
| SG&A Expense | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $3M | $4M | $3M | $4M | $4M | |
| Operating Expenses | $23M | $23M | $20M | $22M | $23M | $23M | $20M | $22M | $23M | $24M | $21M | $21M | $19M | $18M | $17M | $17M | |
| Operating Income | $-9M | $-11M | $-7M | $-8M | $-9M | $-10M | $-8M | $-9M | $-12M | $-5M | $-10M | $-10M | $-11M | $-9M | $-9M | $-10M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $1M | $1M | $1M | $1M | · | $1M | $934.0K | |
| Other Non-op | $157.0K | $366.0K | $277.0K | $152.0K | $379.0K | $479.0K | $285.0K | $337.0K | $301.0K | $497.0K | $558.0K | $870.0K | $473.0K | $634.0K | $-195.0K | $-342.0K | |
| Pretax Income | $-11M | $-12M | $-9M | $-9M | $-10M | $-11M | $-9M | $-10M | $-13M | $-6M | · | · | · | · | · | · | |
| Income Tax | $60.0K | $60.0K | $145.0K | $0 | $33.0K | $52.0K | · | · | · | · | · | · | · | · | · | · | |
| Net Income | $-11M | $-12M | $-9M | $-9M | $-10M | $-11M | $-9M | $-10M | $-13M | $-6M | $-11M | $-11M | $-12M | $-10M | $-11M | $-13M | |
| EPS (Basic) | $-0.20 | $-0.21 | $-0.17 | $-0.19 | $-0.22 | $-0.25 | $-0.17 | $-0.42 | $-0.51 | $-0.23 | $-0.45 | $-0.46 | $-0.63 | $-0.45 | $-0.64 | $-0.88 | |
| EPS (Diluted) | $-0.20 | $-0.21 | $-0.17 | $-0.19 | $-0.22 | $-0.25 | $-0.17 | $-0.42 | $-0.51 | $-0.23 | $-0.45 | $-0.46 | $-0.63 | $-0.45 | $-0.64 | $-0.88 | |
| Shares (Basic) | 57,414,360 | 57,256,518 | · | 45,421,795 | 45,365,325 | 45,267,020 | · | 24,703,578 | 24,663,234 | 24,579,386 | 24,483,664 | 23,239,262 | 19,185,621 | · | 16,758,573 | 14,557,453 | |
| Shares (Diluted) | 57,414,360 | 57,256,518 | · | 45,421,795 | 45,365,325 | 45,267,020 | · | 24,703,578 | 24,663,234 | 24,579,386 | 24,483,664 | 23,239,262 | 19,185,621 | · | 16,758,573 | 14,557,453 | |
| EBITDA | $-9M | $-11M | · | $-8M | $-9M | $-10M | · | $-9M | $-12M | $-5M | $-10M | $-10M | $-11M | · | $-9M | $-10M |
Bilanço
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $30M | $40M | $51M | $30M | $35M | $43M | $53M | $17M | $26M | $37M | $58M | $65M | $30M | · | $54M | $28M | |
| Receivables | $10M | $10M | $10M | $11M | $11M | $11M | $10M | $11M | $9M | $10M | $8M | $8M | $7M | · | $6M | $5M | |
| Inventory | $11M | $12M | $11M | $12M | $11M | $14M | $13M | $14M | $13M | $14M | $14M | $14M | $15M | · | $12M | $10M | |
| Prepaid Expense | $3M | $3M | $3M | $4M | $3M | $3M | $3M | $2M | $2M | $2M | $2M | $2M | $2M | · | $2M | $2M | |
| Current Assets | $54M | $64M | $76M | $56M | $61M | $70M | $78M | $44M | $51M | $63M | $82M | $89M | $54M | · | $74M | $46M | |
| PP&E (Net) | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | · | $2M | $2M | |
| PP&E (Gross) | · | · | $6M | · | · | · | $7M | · | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | · | · | $3M | · | · | · | $5M | · | · | · | · | · | · | · | · | · | |
| Intangibles | $1M | $1M | $1M | $1M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | · | $3M | $3M | |
| Other Non-current Assets | $451.0K | $476.0K | $500.0K | · | $1M | $2M | $2M | $3M | $3M | $3M | · | · | · | · | · | · | |
| Total Assets | $60M | $70M | $81M | $62M | $68M | $77M | $87M | $53M | $60M | $72M | $87M | $94M | $59M | · | $80M | $51M | |
| Accounts Payable | $3M | $4M | $2M | $2M | $2M | $4M | $2M | $2M | $2M | $3M | $3M | $2M | $5M | · | $5M | $2M | |
| Accrued Liabilities | $15M | $14M | $16M | $15M | $14M | $13M | $13M | $14M | $13M | $12M | $12M | $11M | $9M | · | $10M | · | |
| Current Liabilities | $18M | $18M | $18M | $17M | $19M | $17M | $16M | $17M | $15M | $15M | $15M | $13M | $14M | · | $15M | $12M | |
| Capital Leases | · | · | · | · | · | · | $2M | · | · | · | $1M | $1M | $1M | · | $1M | $1M | |
| Other Non-current Liabilities | $1M | $1M | $1M | $2M | $1M | $1M | $1M | $1M | $2M | $2M | $1M | $1M | $1M | · | $1M | $1M | |
| Total Liabilities | $76M | $75M | $75M | $60M | $58M | $59M | $58M | $59M | $57M | $57M | $57M | $54M | $56M | · | $56M | $53M | |
| Long-term Debt | · | · | · | · | $41M | $41M | · | $41M | $41M | $41M | $40M | $40M | $40M | · | $40M | $40M | |
| Total Debt | $56M | $56M | · | $41M | $41M | $41M | · | $41M | $41M | $41M | $40M | $40M | $40M | · | $40M | $40M | |
| Common Stock | $45.0K | $45.0K | $44.0K | $40.0K | $40.0K | $40.0K | $39.0K | $25.0K | $25.0K | $25.0K | $24.0K | $24.0K | $19.0K | · | $19.0K | $15.0K | |
| Paid-in Capital | $405M | $405M | $404M | $390M | $389M | $388M | $387M | $343M | $342M | $341M | $338M | $337M | $289M | · | $287M | $252M | |
| Retained Earnings | $-421M | $-410M | $-398M | $-389M | $-380M | $-370M | $-359M | $-350M | $-339M | $-327M | $-308M | $-297M | $-286M | · | $-264M | $-254M | |
| AOCI | $84.0K | $85.0K | $91.0K | $91.0K | $93.0K | $91.0K | $90.0K | $149.0K | $98.0K | $97.0K | $135.0K | $84.0K | $120.0K | · | $262.0K | $129.0K | |
| Stockholders' Equity | $-16M | $-5M | $6M | $2M | $9M | $18M | $28M | $-6M | $3M | $14M | $31M | $40M | $3M | $14M | $23M | $-2M | |
| Liabilities + Equity | $60M | $70M | $81M | $62M | $68M | $77M | $87M | $53M | $60M | $72M | $87M | $94M | $59M | · | $80M | $51M | |
| Shares Outstanding | 44,833,942 | 44,765,928 | 44,538,264 | 40,341,535 | 39,584,178 | 39,554,771 | 39,395,712 | 24,717,193 | 24,675,832 | 24,653,939 | 24,487,578 | 24,475,504 | 19,227,777 | · | 19,159,145 | 14,557,560 |
Nakit Akışı
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $613.0K | $816.0K | $812.0K | $955.0K | $985.0K | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | |
| Deferred Tax | · | · | $59.0K | $0 | $33.0K | $52.0K | · | · | · | · | · | · | · | · | · | · | |
| Operating Cash Flow | $-9M | $-11M | $-5M | $-6M | $-8M | $-10M | $-8M | $-9M | $-11M | $-14M | $-7M | $-11M | $-12M | $-11M | $-8M | $-12M | |
| CapEx | $59.0K | $119.0K | $91.0K | $211.0K | $114.0K | $32.0K | $264.0K | $122.0K | $299.0K | $304.0K | $134.0K | $157.0K | $115.0K | $46.0K | $290.0K | $200.0K | |
| Investing Cash Flow | $239.0K | $190.0K | $192.0K | $312.0K | $204.0K | $138.0K | $-190.0K | $-122.0K | $67.0K | $5M | $-134.0K | $-157.0K | $-115.0K | $-1M | $-290.0K | $-200.0K | |
| Debt Issued | · | · | · | · | · | · | · | · | · | · | · | · | · | $0 | $0 | · | |
| Stock Issued | · | · | · | · | · | · | · | · | · | · | $-13.0K | · | · | · | · | · | |
| Financing Cash Flow | $-15.0K | $-298.0K | $26M | $24.0K | $-3.0K | $-116.0K | $43M | $98.0K | $-5.0K | $56.0K | $71.0K | $46M | $-235.0K | $-219.0K | $35M | $7M | |
| Net Change in Cash | $-9M | $-11M | $21M | $-5M | $-8M | $-10M | $35M | $-9M | $-11M | $-10M | $-7M | $35M | $-12M | $-12M | $27M | $-5M | |
| Free Cash Flow | · | $-11M | · | · | · | $-10M | · | · | · | $-15M | · | · | $-12M | · | · | · |
Kârlılık
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 72.3% | 65.7% | · | 67.5% | 69.8% | 67.6% | · | 67.8% | 68.8% | 68.3% | 69.0% | 70.4% | 66.3% | · | 65.6% | 62.9% | |
| Operating Margin | -48.1% | -55.2% | · | -36.5% | -45.0% | -56.5% | · | -49.4% | -71.9% | -29.1% | -67.6% | -71.5% | -94.5% | · | -85.0% | -98.4% | |
| Net Margin | -58.4% | -64.4% | · | -41.6% | -49.1% | -60.8% | · | -54.7% | -78.3% | -34.1% | -72.8% | -74.4% | -101.0% | · | -96.0% | -122.4% | |
| Pretax Margin | -58.1% | -64.1% | · | -41.6% | -49.0% | -60.5% | · | · | · | · | · | · | · | · | · | · | |
| EBITDA Margin | -48.1% | -55.2% | · | -36.5% | -45.0% | -56.5% | · | -49.4% | -71.9% | -29.1% | -67.6% | -71.5% | -94.5% | · | -85.0% | -98.4% | |
| ROA | -17.7% | -16.7% | · | -15.0% | -15.5% | -15.1% | · | -14.8% | -16.3% | -8.7% | -13.1% | -14.8% | -21.1% | · | -14.4% | -20.4% | |
| ROE | 337.1% | -190.0% | · | 364.9% | -164.6% | -69.3% | · | -85.4% | -58.8% | -64.6% | -40.7% | -56.1% | -182.5% | · | -42.0% | -76.2% | |
| ROIC | -23.2% | -20.9% | · | · | -18.0% | -17.7% | · | · | · | · | · | · | · | · | · | · |
Likidite ve Solventlik
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.0 | 3.6 | · | 3.3 | 3.2 | 4.2 | · | 2.6 | 3.4 | 4.1 | 5.4 | 6.8 | 3.7 | · | 4.9 | 3.8 | |
| Quick Ratio | 2.2 | 2.8 | · | 2.4 | 2.4 | 3.2 | · | 1.7 | 2.4 | 3.1 | 4.3 | 5.6 | 2.6 | · | 3.9 | 2.8 | |
| Debt / Equity | -3.5 | -10.7 | · | 26.6 | 4.5 | 2.3 | · | -6.5 | 14.2 | 2.8 | 1.3 | 1.0 | 12.8 | · | 1.7 | -25.7 | |
| LT Debt / Equity | -3.5 | -10.7 | · | 26.6 | 4.1 | 2.3 | · | -6.5 | 14.2 | 2.8 | 1.3 | 1.0 | 12.8 | · | 1.7 | -25.7 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | -3.6 | -7.6 | -8.0 | -9.0 | · | -9.2 | -11.0 |
Verimlilik
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.3 | 0.3 | · | 0.4 | 0.3 | 0.2 | · | 0.3 | 0.2 | 0.3 | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.2 | |
| Receivables Turnover | 1.8 | 1.9 | · | 1.8 | 2.0 | 1.8 | · | 2.0 | 1.9 | 2.0 | 2.2 | 2.2 | 2.2 | · | 2.4 | 2.4 |
Hisse Başına
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $-0.35 | $-0.12 | · | $0.04 | $0.23 | $0.46 | · | $-0.25 | $0.12 | $0.58 | $1.25 | $1.63 | $0.16 | · | $1.22 | $-0.11 | |
| Revenue / Share | $0.34 | $0.33 | · | $0.46 | $0.45 | $0.41 | · | $0.77 | $0.65 | $0.68 | $0.61 | $0.62 | $0.62 | · | $0.67 | $0.71 | |
| Cash Flow / Share | · | $-0.20 | · | · | · | $-0.21 | · | · | · | $-0.59 | · | · | $-0.60 | · | · | · | |
| Cash / Share | $0.68 | $0.88 | · | $0.74 | $0.88 | $1.08 | · | $0.70 | $1.07 | $1.51 | $2.38 | $2.67 | $1.57 | · | $2.83 | $1.90 | |
| EPS (TTM) | $-0.77 | $-0.79 | · | $-0.83 | $-1.06 | $-1.35 | · | $-1.66 | $-1.69 | $-1.64 | $-1.99 | $-2.18 | $-2.60 | · | $-2.87 | $-2.80 |
Değerleme (TTM)
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $80M | $81M | · | $77M | $75M | $71M | · | $69M | $65M | $63M | $53M | $49M | $45M | · | $38M | $35M | |
| Net Income TTM | $-41M | $-40M | · | $-39M | $-41M | $-43M | · | $-42M | $-42M | $-40M | $-44M | $-44M | $-45M | · | $-43M | $-40M | |
| Market Cap | $34M | $28M | · | $60M | $77M | $48M | · | $63M | $116M | $140M | $196M | $248M | $205M | · | $163M | $102M | |
| Enterprise Value | $59M | $44M | · | $72M | $83M | $47M | · | $86M | $130M | $143M | $178M | $223M | $215M | · | $149M | $114M | |
| P/E | -1.0 | -0.8 | · | -1.8 | -1.8 | -0.9 | · | -1.5 | -2.8 | -3.5 | -4.0 | -4.6 | -4.1 | · | -3.0 | -2.5 | |
| P/S | 0.4 | 0.3 | · | 0.8 | 1.0 | 0.7 | · | 0.9 | 1.8 | 2.2 | 3.7 | 5.0 | 4.5 | · | 4.3 | 2.9 | |
| P/B | -2.1 | -5.3 | · | 38.6 | 8.4 | 2.7 | · | -10.0 | 40.4 | 9.7 | 6.4 | 6.2 | 65.1 | · | 7.0 | -66.2 | |
| P / Tangible Book | · | · | · | 583.6 | 10.1 | 2.9 | · | · | 123.2 | 11.3 | 6.9 | 6.6 | 277.6 | · | 7.9 | · | |
| P / Cash Flow | · | -2.5 | · | · | · | -5.0 | · | · | · | -9.7 | · | · | -17.7 | · | · | · | |
| EV / Revenue | 0.7 | 0.5 | · | 0.9 | 1.1 | 0.7 | · | 1.3 | 2.0 | 2.3 | 3.4 | 4.5 | 4.8 | · | 3.9 | 3.3 | |
| Earnings Yield | -102.7% | -127.4% | · | -55.7% | -54.6% | -110.7% | · | -65.6% | -36.0% | -28.9% | -24.9% | -21.5% | -24.4% | · | -33.7% | -39.9% |
En son dönem solda · null değerler · olarak gösterilir
Finansal Tablolar Gelir tablosu, bilanço, nakit akışı — yıllık, son 5 yıl
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Gelir | $80M | $69M | $58M | $41M | $29M |
| Brüt Kâr Marjı % | 67.7% | 67.1% | 68.6% | 65.3% | 63.8% |
| Faaliyet Kâr Marjı % | -42.0% | -49.2% | -75.4% | -94.2% | -100.0% |
| Net Gelir | $-39M | $-38M | $-47M | $-44M | $-33M |
| Seyreltilmiş Hisse Başı Kâr | $-0.83 | $-1.33 | $-2.04 | $-2.72 | $-2.30 |
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Borç / Öz Sermaye | 8.8 | 1.4 | 2.1 | 2.8 | · |
| Cari Oran | 4.2 | 5.0 | 4.2 | 5.0 | 5.6 |
| Cari Oran | 3.4 | 4.0 | 3.3 | 3.9 | 4.6 |
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Serbest Nakit Akışı | $-29M | $-43M | $-41M | $-42M | $-31M |
Kurumsal Sahipler (13F) 46 dosya · $21.5M toplam · Tarih itibarıyla 30 Haziran 2026
Çeyreklik SEC Form 13F'lerinde bu hisse senedini tuttuklarını bildiren kurumlar. Yalnızca uzun pozisyonlar; tek bir başvuru sahibi, ayrı opsiyon bacakları için iki kez görünebilir. Büyük dengeleyici alım/satım bacakları genellikle piyasa yapımını veya korunmuş envanteri yansıtır, yönlü bir inancı değil.
Sahipler
46
Tutulan Değer
$21.5M
Yeni pozisyonlar
10
Çıkan pozisyonlar
1
Kurumsal faaliyet — Q2 2026 ve önceki çeyrek
| Yeni pozisyonlar | Çıkan pozisyonlar | Artırıldı | Azaldı | Net hisse senedi değişimi |
|---|---|---|---|---|
| 10 (+6 önceki Ç'ye göre) | 1 (-8 önceki Ç'ye göre) | 12 (-2 önceki Ç'ye göre) | 10 (+6 önceki Ç'ye göre) | -1.9M |
Q1 2026 ile karşılaştırıldı. SEC Form 13F başvuruları, çeyrek sonundan itibaren 45 gün içinde ve geç başvuranlar için kısa bir ek süre içinde tamamlanmalıdır — bu pencere içindeki çeyrekler, en son tam olarak raporlanan çifte tercih edilerek atlanır.
| Kurum | Değer | Hisse senetleri | % izlenen 13F'nin | Tür |
|---|---|---|---|---|
| Essex Woodlands Management, Inc. | $5.786.032 | 7.714.709 | 26,93% | Hisse senetleri |
| Nantahala Capital Management, LLC | $4.420.586 | 5.894.114 | 20,58% | Hisse senetleri |
| VANGUARD GROUP INC | $2.160.049 | 1.830.550 | 10,05% | Hisse senetleri |
| Stonepine Capital Management, LLC | $1.996.820 | 2.662.427 | 9,29% | Hisse senetleri |
| SILVERARC CAPITAL MANAGEMENT, LLC | $1.602.901 | 2.137.201 | 7,46% | Hisse senetleri |
| VANGUARD CAPITAL MANAGEMENT LLC | $1.176.164 | 1.568.218 | 5,47% | Hisse senetleri |
| DAFNA Capital Management LLC | $1.080.772 | 1.441.029 | 5,03% | Hisse senetleri |
| PERKINS CAPITAL MANAGEMENT INC | $1.031.281 | 1.375.042 | 4,80% | Hisse senetleri |
| Sio Capital Management, LLC | $477.225 | 636.300 | 2,22% | Hisse senetleri |
| WealthTrust Axiom LLC | $343.300 | 457.734 | 1,60% | Hisse senetleri |
| GEODE CAPITAL MANAGEMENT, LLC | $291.952 | 389.223 | 1,36% | Hisse senetleri |
| BlackRock, Inc. | $280.887 | 374.516 | 1,31% | Hisse senetleri |
| VANGUARD FIDUCIARY TRUST CO | $159.854 | 213.138 | 0,74% | Hisse senetleri |
| UP STRATEGIC WEALTH INVESTMENT ADVISORS LLC | $91.398 | 99.888 | 0,43% | Hisse senetleri |
| Embree Financial Group | $68.180 | 90.906 | 0,32% | Hisse senetleri |
| NORTHERN TRUST CORP | $56.093 | 74.790 | 0,26% | Hisse senetleri |
| RAYMOND JAMES FINANCIAL INC | $50.775 | 67.700 | 0,24% | Hisse senetleri |
| STATE STREET CORP | $47.537 | 63.383 | 0,22% | Hisse senetleri |
| RENAISSANCE TECHNOLOGIES LLC | $43.575 | 58.100 | 0,20% | Hisse senetleri |
| PNC Financial Services Group, Inc. | $40.209 | 53.612 | 0,19% | Hisse senetleri |
| Destiny Wealth Partners, LLC | $38.320 | 52.500 | 0,18% | Hisse senetleri |
| Ducere Wealth Management LLC | $38.250 | 51.000 | 0,18% | Hisse senetleri |
| JANE STREET GROUP, LLC | $36.933 | 49.245 | 0,17% | Hisse senetleri |
| UBS Group AG | $25.100 | 33.466 | 0,12% | Hisse senetleri |
| XTX Topco Ltd | $22.169 | 29.558 | 0,10% | Hisse senetleri |
| TD Waterhouse Canada Inc. | $16.560 | 23.000 | 0,08% | Hisse senetleri |
| PRIMORIS WEALTH ADVISORS, LLC | $15.225 | 20.300 | 0,07% | Hisse senetleri |
| GREAT VALLEY ADVISOR GROUP, INC. | $14.702 | 19.602 | 0,07% | Hisse senetleri |
| J.W. COLE ADVISORS, INC. | $12.188 | 16.250 | 0,06% | Hisse senetleri |
| Atom Investors LP | $11.605 | 15.473 | 0,05% | Hisse senetleri |
| MERCER GLOBAL ADVISORS INC /ADV | $11.121 | 14.828 | 0,05% | Hisse senetleri |
| Tower Research Capital LLC (TRC) | $10.209 | 13.612 | 0,05% | Hisse senetleri |
| HighTower Advisors, LLC | $8.400 | 11.200 | 0,04% | Hisse senetleri |
| GOLDMAN SACHS GROUP INC | $7.787 | 10.383 | 0,04% | Hisse senetleri |
| Vanguard Global Advisers, LLC | $3.453 | 4.604 | 0,02% | Hisse senetleri |
| WELLS FARGO & COMPANY/MN | $3.150 | 4.200 | 0,01% | Hisse senetleri |
| Steward Partners Investment Advisory, LLC | $1.493 | 1.991 | 0,01% | Hisse senetleri |
| CITIGROUP INC | $1.331 | 1.774 | 0,01% | Hisse senetleri |
| SIMPLEX TRADING, LLC | $957 | 1.276 | 0,00% | Hisse senetleri |
| SBI Securities Co., Ltd. | $226 | 301 | 0,00% | Hisse senetleri |
| BNP PARIBAS FINANCIAL MARKETS | $158 | 210 | 0,00% | Hisse senetleri |
| BARCLAYS PLC | $156 | 208 | 0,00% | Hisse senetleri |
| OSAIC HOLDINGS, INC. | $75 | 100 | 0,00% | Hisse senetleri |
| JPMORGAN CHASE & CO | $28 | 39 | 0,00% | Hisse senetleri |
| MORGAN STANLEY | $28 | 37 | 0,00% | Hisse senetleri |
| ROYAL BANK OF CANADA | $0 | 59 | 0,00% | Hisse senetleri |
Aktivistler ve %5+ sahipler 4 pozisyon
SEC Çizelge 13D dosyalayan yatırımcılar — ihraççı üzerinde nüfuz etme niyetiyle %5'in üzerinde faydalı sahiplik (aktivist hisseler, yönetim kurulu kampanyaları, M&A). Her satır, o başvuru sahibinin pozisyonunun bilinen en son durumunu gösterir.
| Başvuru sahibi | Dosyalandı | Hisse | Durum | Amaç | Başvuru |
|---|---|---|---|---|---|
| EW HEALTHCARE PARTNERS FUND 2, L.P., EW HEALTHCARE PARTNERS FUND 2-A, L.P., EW Healthcare Partners Fund 2-GP, L.P., EW Healthcare Partners Fund 2-UGP, LLC ×5 başvurular | 09 Haziran 2026 | 17,23% | İlk başvuru | Yönetim kurulu kampanyası | SEC |
| OrbiMed Advisors LLC, OrbiMed Capital GP IV LLC ×7 başvurular | 25 Ekim 2024 | · | İlk başvuru | · | SEC |
| Açıklanmayan raporlama kişisi | 10 Haziran 2022 | · | İlk başvuru | · | SEC |
| EW Healthcare Partners 2, L.P., EW Healthcare Partners Fund 2-A, L.P., EW Healthcare Partners Fund 2-UGP, LLC, EW Healthcare Partners Fund 2 GP, L.P., Martin P. Sutter, R. Scott Barry, Ronald Eastman, Petri Vainio ×4 başvurular | 01 Haziran 2022 | · | İlk başvuru | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Şirket yöneticileri 27 içeriden öğrenenler · 11 yöneticiler · 17 yönetim kurulu üyeleri
| İçeriden Öğrenen | Rol | Son işlem | Sahip olunan hisse senetleri | Alımlar 12ay | Satışlar 12ay | Net 12ay |
|---|---|---|---|---|---|---|
| Heather C Getz | Chief Executive Officer | 17 Ağustos 2026 P | 532.500 | 2 | 0 | $18.750 |
| Antony Koblish | Chief Executive Officer | 20 Şubat 2026 A | 586.210 | 0 | 0 | $0 |
| Roberto Cuca | COO and CFO | 20 Şubat 2026 A | 257.377 | 0 | 0 | $0 |
| Nora Brennan | Chief Financial Officer | 31 Mart 2021 A | 17.696 | 0 | 0 | $0 |
| Jeffrey Blizard | President | 20 Şubat 2026 A | 205.125 | 0 | 0 | $0 |
| Megan Smeykal | Chief Accounting Officer | 23 Şubat 2026 F | 66.873 | 0 | 0 | $0 |
| Gregory A. Firestone | Chief Business Officer | 20 Şubat 2026 A | 139.307 | 0 | 0 | $0 |
| Paul Talmo | Chief Technology Officer | 20 Şubat 2026 A | 173.436 | 0 | 0 | $0 |
| Peter C. Murphy | Chief Commercial Officer | 31 Mart 2024 F | 48.129 | 0 | 0 | $0 |
| Ellis Skott Greenhalgh | Chief Technology Officer | 24 Şubat 2022 F | 27.826 | 0 | 0 | $0 |
| Maarten Persenaire | Chief Medical Officer | 24 Şubat 2021 A | 90.887 | 0 | 0 | $0 |
| Joseph H Capper | Yönetim kurulu üyesi | 17 Eylül 2026 P | 179.827 | 4 | 0 | $167.500 |
| William J. Plovanic | Yönetim kurulu üyesi | 15 Temmuz 2026 A | 44.530 | 0 | 0 | $0 |
| Betty Jo Rocchio | Yönetim kurulu üyesi | 09 Haziran 2026 A | 23.600 | 0 | 0 | $0 |
| Guido J Neels | Yönetim kurulu üyesi | 09 Haziran 2026 A | 23.600 | 0 | 0 | $0 |
| Guy P Nohra | Yönetim kurulu üyesi | 09 Haziran 2026 A | 23.600 | 0 | 0 | $0 |
| Paul Thomas | Yönetim kurulu üyesi | 09 Haziran 2026 A | 23.600 | 0 | 0 | $0 |
| Kurt Azarbarzin | Yönetim kurulu üyesi | 28 Mayıs 2025 A | 18.470 | 0 | 0 | $0 |
| Vincent J Burgess | Yönetim kurulu üyesi | 28 Mayıs 2025 A | 23.330 | 0 | 0 | $0 |
| Douglas G Evans | Yönetim kurulu üyesi | 28 Mayıs 2025 A | 18.470 | 0 | 0 | $0 |
| Lisa N Colleran | Yönetim kurulu üyesi | 28 Mayıs 2025 A | 18.470 | 0 | 0 | $0 |
| Federica F. O'Brien | Yönetim kurulu üyesi | 28 Mayıs 2025 A | 18.470 | 0 | 0 | $0 |
| John Nosenzo | Yönetim kurulu üyesi | 01 Haziran 2023 A | 6.270 | 0 | 0 | $0 |
| Adele C Oliva | Yönetim kurulu üyesi | 04 Haziran 2020 A | 1.751.100 | 0 | 0 | $0 |
| Matt Zuga | Yönetim kurulu üyesi | 13 Kasım 2019 C | 498.606 | 0 | 0 | $0 |
| Ashley Friedman | Yönetim kurulu üyesi | 13 Kasım 2019 C | 505.281 | 0 | 0 | $0 |
| Opaleye Management Inc. | 10% sahip | 03 Kasım 2022 P | 124.813 | 0 | 0 | $0 |
SEC Form 3/4/5 başvurularından yöneticiler; net = yalnızca açık piyasa Alış/Satış
ETF sahipliği 2 ETF'ler tarafından tutuluyor
Ağırlık yalnızca doğrudan öz sermaye varlıklarını (N-PORT) yansıtır; kaldıraçlı veya türev tabanlı fonlar gösterilmeyen ek swap pozisyonlarına sahip olabilir.
TELA Analist Uzlaşması Boğa ve ayı analist görüşleri, 12 aylık fiyat hedefi, yukarı yönlü potansiyel
derecelendirme · 11 analist
AL
Medyan hedef
$2.00
+75,4%
3 27,3%
Güçlü Al
6 54,5%
Al
2 18,2%
Tut
0 0,0%
Sat
0 0,0%
Güçlü Sat
12 Aylık Fiyat Hedefi
6 analist · 2026-10-03Ortalama hedef $2.08 +82,7%
Şimdi
Mevcut fiyat $1.14
Düşük$1.00
Ortalama$2.08
Yüksek$3.00
Akran karşılaştırması (GICS alt sektörü) Anahtar metrikler sektördeki benzerlerine karşı
Mali yıl bazında, fiyatlar her şirketin son mali yıl kapanışına göredir.
| Hisse Sembolü | Piyasa Değeri | P/E | Gelir YoY | Net Kar Marjı | ROE | Brüt Kar Marjı |
|---|---|---|---|---|---|---|
| TELA | $53M | -1.4 | 15.8% | -48.4% | -501.1% | 67.7% |
| UTMD | $178M | 16.1 | -5.8% | 29.3% | 9.5% | 57.1% |
| RXST | $430M | -11.0 | -3.9% | -29.0% | -14.0% | 76.6% |
| SKYA | · | · | · | · | · | · |
| RMTI | $33M | -5.5 | -31.8% | -7.7% | -15.8% | 16.9% |
| NSPR | $77M | -2.3 | 28.1% | -543.3% | -129.3% | 29.5% |
| ADVB | $15M | -4.4 | · | · | -159.1% | · |
Metriklerim Kişisel izleme listeniz — Tam Temeller'den seçilen satırlar
Sizin için önemli olan metrikleri seçin — Yukarıdaki Tam Temeller bölümündeki herhangi bir satırın yanındaki + işaretine tıklayın.
Seçiminiz kaydedildi ve tüm hisse senetlerinde sizinle birlikte gelir.
Kaynak: SEC 10-Q dosyalandı Ağu 11, 2026